Alabama Cancer Congress


Within several years of establishment, the Alabama Cancer Congress has become the leading representative body of providers for cancer medicine in the state of Alabama. The continued commitment of promoting education, advocacy, and a sense of community for professional medical cancer organizations, has led us to be recognized by the Legislature within the State.

Our website provides information regarding statewide oncologic organizations, links to oncology resources, and recent meeting presentations. Each member of the Alabama Cancer Congress executive board encourages feedback and collaboration from our members. In this dynamic healthcare environment we must continue to provide excellent patient care while supporting the interests of cancer medicine providers in Alabama.

Our main mission is to serve as a sustainable inclusive representative body of all providers of cancer medicine in the state of Alabama – promoting education, advocacy and sense of community.


ACC corporate membership provides businesses with the opportunity to align themselves with medical, radiation, gynecologic and neurological oncology practices throughout Alabama. Advertisers are able to reach the oncologists and practice decision makers via advertising in society newsletters, websites, and at business, educational and legislative conferences.


Join Today

CMS Releases Physician Fee Schedule Final Rule
The Centers for Medicare and Medicaid Services (CMS) released the final CY 2019 Physician Fee Schedule (PFS) rule. The agency responded to the overwhelming negative stakeholder response to its proposal to revise evaluation and management (E/M) documentation requirements and payment by significantly revising its final policy.

Click here for more.

CMS Releases Final Hospital Outpatient Payment Rule - The Centers for Medicare and Medicaid Services (CMS) released the final CY 2019 Hospital Outpatient Prospective Payment System (OPPS) rule. In the Society’s comment letter, ASH requested that CMS change the status indicator for the four new Category III CPT codes for chimeric antigen receptor (CAR) T-cell therapy from “B” to “S.” In the final rule, CMS did finalize this change for one of the four codes, code 0540T, CAR-T cell administration, autologous. 

Click here for the report.


Upcoming Events

ACC-MOS 2019 Joint Spring Conference
April 12-13, 2019
Marriott Grand Hotel
Point Clear, Alabama

Click here for registration information.

Exhibitors: contact [email protected]



ASCO has announced fifteen distinguished members selected by the Nominating Committee as candidates for open leadership positions within the Society. From November 1 to December 3, 2018, eligible ASCO members are encouraged to vote to choose new leaders and on proposed amendments to the ASCO Bylaws. To learn more about the candidates, click here and log into your ASCO account.

8 Medicare and Medicaid reforms that would have the biggest impact on federal spending

Click here for more